Clinical trials
Completed trials in Malaysia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
463 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 9 |
| 2012 | 17 |
| 2013 | 11 |
| 2014 | 18 |
| 2015 | 15 |
| 2016 | 10 |
| 2017 | 35 |
| 2018 | 34 |
| 2019 | 52 |
| 2020 | 44 |
| 2021 | 37 |
| 2022 | 42 |
| 2023 | 51 |
| 2024 | 37 |
| 2025 | 21 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 463 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Malaya | 85 |
| Universiti Sains Malaysia | 46 |
| National University of Malaysia | 32 |
| Universiti Putra Malaysia | 28 |
| Universiti Kebangsaan Malaysia Medical Centre | 25 |
| Malaysia Palm Oil Board | 18 |
| USMARI Research & Innovation Centre | 11 |
| Universiti Tunku Abdul Rahman | 11 |
| Universiti Teknologi Mara | 10 |
| Clinical Research Centre, Malaysia | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 21 |
| Anxiety Disorders | 15 |
| Obesity | 15 |
| Overweight | 12 |
| Diabetes Mellitus | 10 |
| Stroke | 10 |
| Insulin Resistance | 9 |
| Heart Failure | 7 |
| Cardiovascular Diseases | 5 |
| Hypertension | 5 |
Trials
Showing 1 to 25 of 463. Each trial links to its page on Pharma Observatory.
363 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.